DBVT earnings date and last-quarter result: next report 2026-10-27, last quarter miss, P/E -3.53. Updated 2026-07-23.
DBV Technologies (DBVT) Research Hub
DBV Technologies (DBVT) trades on NASDAQ, FR in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 9.98 USD (+2.36%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.53, market cap 0.33B. This hub links to the full technical, earnings and options research available for DBVT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, FR |
| Last close | 9.98 USD (+2.36%) |
| 52-week range | 8.63 USD – 18.5 USD |
| Trend regime | Range |
| 14-day RSI | 50 (Neutral) |
| Trailing P/E | -3.53 |
| Market cap | 0.33B |
| Dividend yield | 0.00% |
| Next earnings | 2026-10-27 |
Available research for DBVT
Covered Call on DBVT: how it works, illustrative setup around the real 9.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DBVT: how it works, illustrative setup around the real 9.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DBVT: how it works, illustrative setup around the real 9.98 USD price, max profit/loss, breakeven and when to use it. Educational.
DBVT technical analysis: range, last 9.98 USD, RSI 50, 52w range 8.63 USD–18.5 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is DBVT in?
DBV Technologies (DBVT) is classified under Healthcare (Biotechnology), listed on NASDAQ, FR.
Is DBVT in an uptrend or downtrend?
As of 2026-10-26, DBVT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DBVT's trailing P/E ratio?
DBVT's trailing P/E is -3.53, with a market cap of 0.33B. See the earnings research page for full valuation detail.
When does DBVT next report earnings?
DBVT is next scheduled to report earnings on 2026-10-27.